Article

A Comprehensive Immunologic Portrait of Triple-Negative Breast Cancer

2017-10-26

Abstract excerpt

<h4>Background</h4> Triple-negative breast cancer (TNBC) is a high-risk malignancy due to its high capacity for invasion and lack of targeted therapy. Immunotherapy continues to demonstrate efficacy in a variety of cancers, and thus may be a promising strategy for TNBC given the limited therapeutic options currently available for TNBC. In this study, we performed a comprehensive portrait of immunologic landscape...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 16921204-fa9a-5427-892f-0e756a6ea95d
DOI: 10.1101/209288

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

A Comprehensive Immunologic Portrait of Triple-Negative Breast CancerDOI 10.1101/209288Read

A comprehensive analysis of immune landscape of Indian triple negative breast cancerSemantic proximity Read

Classification of triple-negative breast cancers based on Immunogenomic profilingSemantic proximity Read

Immune Milieu and Genomic Alterations Set the Triple-Negative Breast Cancer Immunomodulatory Subtype Tumor BehaviorSemantic proximity Read

Immune Classification and Immune Landscape Analysis of Triple-Negative Breast CancerSemantic proximity Read

Immune Microenvironment-Related Genes Contribute to Clinical Prognosis in Patients with Triple-Negative Breast CancerSemantic proximity Read

Genomic and transcriptomic analyses identify distinctive features of triple-negative inflammatory breast cancerSemantic proximity Read

Triple negative breast cancer (TNBC): Non-genetic tumor heterogeneity and immune microenvironment: Emerging treatment optionsSemantic proximity Read

Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease.Semantic proximity Read

Immune checkpoints expression patterns predict prognosis and immune microenvironment remodeling in triple-negative breast cancerSemantic proximity Read

Immunogenomic Landscape in Breast Cancer Reveals Immunotherapeutically Relevant Gene Signatures.Semantic proximity Read

Tumor-Infiltrating Lymphocytes Display Prognostic Signatures Associated with Chemotherapy Response in TNBC PatientsSemantic proximity Read

<i>TP53</i> mutations promote immunogenic activity in breast cancerSemantic proximity Read